Peptidomics of prolyl endopeptidase in the central nervous system.
about
The pharmacological landscape and therapeutic potential of serine hydrolasesRecent advances in quantitative neuroproteomicsProteolysis controls endogenous substance P levelsProteasome inhibitors alter levels of intracellular peptides in HEK293T and SH-SY5Y cellsOn-line solid-phase extraction LC-MS/MS for the determination of Ac-SDKP peptide in human plasma from hemodialysis patients.Analysis of the proteolysis of bioactive peptides using a peptidomics approach.Exploring metabolic pathways and regulation through functional chemoproteomic and metabolomic platformsPeptidomics of the prolyl peptidasesA peptidomics strategy to elucidate the proteolytic pathways that inactivate peptide hormones.A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors.The metabolic serine hydrolases and their functions in mammalian physiology and disease.Investigating endogenous peptides and peptidases using peptidomicsPeptidomics methods for the identification of peptidase-substrate interactionsProlyl endopeptidase-deficient mice have reduced synaptic spine density in the CA1 region of the hippocampus, impaired LTP, and spatial learning and memory.Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.A novel secreted metalloprotease (CD2830) from Clostridium difficile cleaves specific proline sequences in LPXTG cell surface proteins.Colocalization of amanitin and a candidate toxin-processing prolyl oligopeptidase in Amanita basidiocarps.Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?Translational research on prolyl oligopeptidase inhibitors: the long road ahead.Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase
P2860
Q26995817-E6462A8F-95DC-4815-A198-D9832C92CD95Q27000073-9B305CE2-644E-40C8-BB5E-871726EB8BE7Q28534739-5623740F-B5C7-4D08-9412-558AAE95982AQ28541433-80B10ABD-5719-4C05-B056-81C6AFEEA22EQ33876682-4C538D44-1DB4-4176-B525-FB27963963BEQ34222114-31739343-1A71-4F44-8D7C-633145395C58Q34228026-BC20F385-3E45-4492-BA93-54CDFCC3D995Q34293605-2414C6CB-1010-45D0-A198-9C92F2CE6682Q34795373-2994EF26-657B-48E2-BD7D-A6BC825CB57AQ35131941-88899780-FF5F-4241-8E24-448999DD6D07Q35333042-9D992C59-A40F-44F1-A1AB-E6FEDAEFA5C6Q36163374-D7A6E379-7426-4C59-A084-7A9C81024C45Q36673769-513BE026-E560-429A-BBA4-E50793F8E866Q37345010-EAD215C5-C431-4599-8E27-30FFCE5F2AF9Q38021639-E914C127-0CCA-4A28-BA3E-26CF40591D52Q38668992-2C5D22ED-278E-41B3-84FB-7FF1CB5AFA32Q39380045-26E11588-0B09-4D48-B647-7B7A962BA46FQ41414865-125D4918-A0FD-4A31-BF0F-E6E1BE36187BQ42028017-549E4263-EF1A-4173-9F55-5E681E28D8BEQ49160469-04B57726-C06A-42A5-A9C7-1C93CC199226Q58695050-DD0711FA-48D6-4686-ACFC-4AD045C2AD36
P2860
Peptidomics of prolyl endopeptidase in the central nervous system.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Peptidomics of prolyl endopeptidase in the central nervous system.
@ast
Peptidomics of prolyl endopeptidase in the central nervous system.
@en
type
label
Peptidomics of prolyl endopeptidase in the central nervous system.
@ast
Peptidomics of prolyl endopeptidase in the central nervous system.
@en
prefLabel
Peptidomics of prolyl endopeptidase in the central nervous system.
@ast
Peptidomics of prolyl endopeptidase in the central nervous system.
@en
P2093
P2860
P356
P1433
P1476
Peptidomics of prolyl endopeptidase in the central nervous system.
@en
P2093
Alan Saghatelian
Debarati M Tagore
Whitney M Nolte
William S Lane
P2860
P304
11971-11981
P356
10.1021/BI901637C
P407
P577
2009-12-01T00:00:00Z